You need cookies enabled

HEFCE closed at the end of March 2018. The information on this website is historical and is no longer maintained.

Many of HEFCE's functions will be continued by the Office for Students, the new regulator of higher education in England, and Research England, the new council within UK Research and Innovation.

The HEFCE domain - www.hefce.ac.uk - will continue to function until September 2018. At this point we will close the site entirely and all its information will only be available from the National Web Archive.

Cookies

You need cookies enabled

The centre will develop the university’s strong research base in Vision Science to include new programmes in diabetes and genomics.  

The relevance these disciplines have to all areas of medical research means that this will help the centre work collaboratively with the rest of the institute and beyond. It is expected that its work will lead to connections with:

  • the wider university
  • other academic institutions
  • the NHS and industry.

It is also expected that the high-quality facilities will attract internationally recognised researchers, and that the drug-discovery and personalised approach to medicine will promote licensing and spin-outs.

Five new bio-tech companies, employing more than 200 people in Northern Ireland, have already been set up by investigators within the institute.

The project has secured a total of £21.7 million from the following sources: The Atlantic Philanthropies, The Wellcome Trust, The Wolfson Foundation, The Sir Jules Thorn Chaaritable Trust, Insight Trust for the Visually Impaired and The Queen’s University of Belfast Foundation.

Page last updated 26 February 2015